Preprints are all around us – but are they relevant and useful or too risky for industry-sponsored research? Two sessions at the 14th Annual Meeting of ISMPP held in Washington this month kicked off the first major public discussions on preprints in our medical communications community.
Open Pharma: a publisher’s perspective
We aimed to gain insight into the publishing industry’s perspective on new innovations in the field, as their collaboration will be key to implementing changes.
Why not use a novel publishing platform?
Questions from delegates at ISMPP US 2017 guided poster tour highlight practical issues presenting barriers to uptake of innovative platforms